Wedbush Downgrades Clementia Pharmaceuticals Inc. (CMTA) to Neutral

February 25, 2019 1:23 PM EST
Get Alerts CMTA Hot Sheet
Price: $26.35 --0%

Rating Summary:
    3 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten downgraded Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) from Outperform to Neutral with a price target of $31.00.

For an analyst ratings summary and ratings history on Clementia Pharmaceuticals Inc. click here. For more ratings news on Clementia Pharmaceuticals Inc. click here.

Shares of Clementia Pharmaceuticals Inc. closed at $14.94 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades